Your trusted destination for CME, CPD & Medical Education across the Middle East.
The conference focuses on oncology, cancer research, and translational medicine, emphasizing the connection between laboratory discoveries and clinical applications. Topics may include cancer biology, molecular and genetic diagnostics, biomarkers, precision medicine, immunotherapy, targeted therapy, chemotherapy, radiation oncology, surgical oncology, drug discovery, clinical trials, artificial intelligence, and emerging approaches to cancer prevention and treatment.
The International Conference on Oncology and Translational Medicine (ICOTM-26) brings together oncologists, physicians, researchers, scientists, healthcare professionals, and biomedical experts to explore advances in cancer research and translational medicine. The conference focuses on translating discoveries from laboratory and clinical research into innovative approaches for cancer prevention, diagnosis, treatment, and patient care. It provides a multidisciplinary platform for sharing research findings, clinical experiences, emerging therapeutic strategies, and developments in precision oncology. Key discussions may address cancer biology, molecular diagnostics, biomarkers, immunotherapy, targeted therapies, radiation oncology, surgical oncology, and novel drug-development approaches. The program also highlights advances in genomics, artificial intelligence, personalized medicine, and clinical research that may contribute to improved cancer management. Participants can exchange knowledge and explore collaborations connecting basic science, translational research, and clinical practice. ICOTM-26 aims to support continued innovation in oncology and strengthen the integration of research discoveries into patient-centered cancer care.
Emerging applications of immunotherapy in oncology and their clinical impact.
Using patient-specific molecular information to guide targeted cancer treatments.
Understanding the cellular mechanisms and pathways of cancer growth.
How tumors interact with surrounding cells and develop resistance to therapies.
Current approaches for translating research discoveries into clinical practice.
Converting laboratory discoveries into advanced diagnostics and patient treatments.
New methodologies and technologies for identifying cancer at earlier stages.
Interventions and early detection programs designed to enhance long-term patient survival.
This conference is accredited by the Saudi Commission for Health Specialties (SCFHS) for 6 CME hours.
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow